Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health
August 05 2024 - 6:45AM
Business Wire
Tenet announces agreement to sell Birmingham
hospitals and related operations; reaffirms latest FY24 Adjusted
EBITDA Outlook
Tenet Healthcare Corporation (NYSE: THC) has entered into a
definitive agreement with Orlando Health for the sale of Tenet’s
70% majority ownership interest in Brookwood Baptist Health in
Birmingham for approximately $910 million in cash (after-tax
proceeds of approximately $790 million).
The transaction will include five hospitals – Brookwood Baptist
Medical Center, Princeton Baptist Medical Center, Walker Baptist
Medical Center, Shelby Baptist Medical Center, Citizens Baptist
Medical Center – as well as affiliated physician practices and
other related operations. Brookwood Baptist Health will remain a
joint venture with Baptist Health System.
Additionally, under the agreement, Tenet’s Conifer Health
Solutions subsidiary will enter into a new and expanded ten-year
contract to provide revenue cycle management services for the
Birmingham hospitals and related operations.
“We are grateful for the partnership with Baptist Health System,
which has enabled us to collectively enhance the high-quality,
compassionate care that Brookwood Baptist Health offers,” said Saum
Sutaria, M.D., Chairman and CEO, Tenet Healthcare. “Orlando Health
is an esteemed, high-performing healthcare organization with an
over century-long commitment to improving the health and wellness
of the communities they serve. Integration of these hospitals into
their network will advance healthcare for the greater Birmingham
communities.”
For the twelve months ended June 30, 2024, Tenet’s equity
interest in the Brookwood Baptist Health joint venture generated
pre-tax income of approximately $12 million and an Adjusted EBITDA
less non-controlling interest of approximately $60 million,
excluding interest expense of approximately $2 million and
depreciation and amortization expense of approximately $46 million.
The company estimates recording a pre-tax book gain of
approximately $375 million as a result of this anticipated
transaction.
The transaction is expected to be completed in the fall of 2024,
subject to customary regulatory approvals, clearances, and closing
conditions.
Tenet also reaffirmed its latest FY24 Adjusted EBITDA Outlook
range included in its second quarter 2024 earnings release.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified
healthcare services company headquartered in Dallas. Our care
delivery network includes United Surgical Partners International,
the largest ambulatory platform in the country, which operates
ambulatory surgery centers and surgical hospitals. We also operate
a national portfolio of acute care and specialty hospitals, other
outpatient facilities, a network of leading employed physicians and
a global business center in Manila, Philippines. Our Conifer Health
Solutions subsidiary provides revenue cycle management and
value-based care services to hospitals, health systems, physician
practices, employers and other clients. Across the Tenet
enterprise, we are united by our mission to deliver quality,
compassionate care in the communities we serve. For more
information, please visit www.tenethealth.com.
Cautionary Statement
This release contains “forward-looking statements” - that is,
statements that relate to future, not past, events. In this
context, forward-looking statements often address the Company’s
expected future business and financial performance and financial
condition, and often contain words such as “expect,” “anticipate,”
“assume,” “believe,” “budget,” “estimate,” “forecast,” “intend,”
“plan,” “predict,” “project,” “seek,” “see,” “target,” or “will.”
Forward-looking statements by their nature address matters that
are, to different degrees, uncertain. Particular uncertainties that
could cause the Company’s actual results to be materially different
than those expressed in the Company’s forward-looking statements
include but are not limited to the factors disclosed under
“Forward-Looking Statements” and “Risk Factors” in our Form 10-K
for the year ended December 31, 2023, and other filings with the
Securities and Exchange Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240805345316/en/
Investor Contact Will McDowell 469-893-2387
William.McDowell@tenethealth.com
Media Contact Robert Dyer 469-893-2640
mediarelations@tenethealth.com
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Jan 2024 to Jan 2025